Compare Heartflow Inc. Common Stock (HTFL) vs uniQure N.V. Ordinary Shares (QURE) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Heartflow Inc. Common Stock vs uniQure N.V. Ordinary Shares — how do they compare? Heartflow Inc. Common Stock trades at $49.44 (market cap $4.38B), while uniQure N.V. Ordinary Shares trades at $20.67 (market cap $1.48B). The key difference: Heartflow Inc. Common Stock is far larger — about 3× uniQure N.V. Ordinary Shares's market cap, and Heartflow Inc. Common Stock is trading nearer its 52-week high, uniQure N.V. Ordinary Shares nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Heartflow Inc. Common Stock for 0 Days and uniQure N.V. Ordinary Shares for 0 Days on average.
| HTFL | QURE | |
|---|---|---|
Market Cap | $4.38B | $1.48B |
Volume | 1,454,420 | 2,488,780 |
Sector | Health | Health |
52-Week High | $52.21 | $70.59 |
52-Week Low | $20.49 | $9.03 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $4.24B | $728.62M |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Heartflow Inc. Common Stock
HeartFlow, Inc. develops AI-powered software that analyzes coronary CT angiography scans to build personalized 3D heart models for coronary artery disease diagnosis, including its FFRct Analysis, Plaque Analysis, and Roadmap Analysis tools.
Read more on HTFL →About uniQure N.V. Ordinary Shares
uniQure N.V. is a biotechnology company that develops gene therapies for rare and severe genetic diseases, marketing HEMGENIX for hemophilia B and advancing its AAV-based miQURE platform in programs such as AMT-130 for Huntington's disease.
Read more on QURE →
